Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000531029 | SCV000638190 | pathogenic | Naxos disease | 2017-08-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln63Argfs*97) in the JUP gene. It is expected to result in an absent or disrupted protein product. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with JUP-related disease. Loss-of-function variants in JUP are known to be pathogenic (PMID: 10902626). For these reasons, this variant has been classified as Pathogenic. |
Labcorp Genetics |
RCV001382209 | SCV001580872 | pathogenic | Naxos disease; Arrhythmogenic right ventricular dysplasia 12 | 2022-03-19 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with JUP-related conditions. This sequence change creates a premature translational stop signal (p.Gln63Argfs*97) in the JUP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in JUP are known to be pathogenic (PMID: 10902626). This variant is not present in population databases (gnomAD no frequency). ClinVar contains an entry for this variant (Variation ID: 464030). For these reasons, this variant has been classified as Pathogenic. |